In this study, we found that there was only a modest effect when using ETC-1002 or Linsitinib alone, while the combination of ETC-1002 and Linsitinib attained dramatic synergy in the suppression of HOXA13-induced CRC metastasis. This evidence concerns the gene HOXA13 and colorectal carcinoma.